J&J | JNJ - Ebit


J&J reported $7.48B in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
AbbVie USD 6.72B 1.99B Jun/2026
Abbott USD 2.13B 281M Jun/2026
Amgen USD 4.61B 777M Jun/2026
AstraZeneca USD 3.16B 3.95B Jun/2026
Baxter International USD 276M 210M Jun/2026
Bayer EUR 755M 2.77B Jun/2026
Becton, Dickinson and Co. USD 752M 125M Jun/2026
Biogen USD -243.8M 758.1M Jun/2026
Boston Scientific USD 1.24B 190M Jun/2026
Bristol-Myers Squibb USD 299M 3.26B Jun/2026
CONMED USD 36.4M 10.99M Jun/2026
Cooper Companies USD 222M 253M Jun/2026
Dexcom USD 318.3M 63M Jun/2026
Edwards Lifesciences USD 519.5M 4.8M Jun/2026
Eli Lilly USD 12.46B 2.68B Jun/2026
Gilead Sciences USD 3.85B 1.17B Jun/2026
GlaxoSmithKline GBP 2.6B 312M Jun/2026
Globus Medical USD -45.97M 209.97M Jun/2026
Insulet USD 129.7M 7.7M Jun/2026
Integra LifeSciences USD 41.29M 29.82M Jun/2026
Intuitive Surgical USD 977.6M 117.9M Jun/2026
J&J USD 7.48B 860M Jun/2026
Medtronic USD 1.84B 254M Jun/2026
Merck USD 840M 2.72B Jun/2026
Merit Medical Systems USD 60.4M 16.25M Jun/2026
Novartis USD 4.73B 549M Jun/2026
Pfizer USD -180M 5.16B Jun/2026
Regeneron Pharmaceuticals USD 1.42B 675.7M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sanofi EUR 1.12B 811M Jun/2026
Stryker USD 1.79B 687M Jun/2026
Tandem Diabetes Care USD -13.79M 4.46M Jun/2026
Teva Pharmaceutical Industries USD 235M 523M Jun/2026
Vertex Pharmaceuticals USD 1.27B 129.9M Jun/2026
Zimmer Biomet Holdings USD 344.7M 50.4M Jun/2026
Zoetis USD 1.12B 279M Jun/2026